ES2048263T3 - Composicion liofilizada de mdm y metodo para su fabricacion. - Google Patents

Composicion liofilizada de mdm y metodo para su fabricacion.

Info

Publication number
ES2048263T3
ES2048263T3 ES89119819T ES89119819T ES2048263T3 ES 2048263 T3 ES2048263 T3 ES 2048263T3 ES 89119819 T ES89119819 T ES 89119819T ES 89119819 T ES89119819 T ES 89119819T ES 2048263 T3 ES2048263 T3 ES 2048263T3
Authority
ES
Spain
Prior art keywords
solution
acid
benzylpenicilloic
benzylpenilloic
mdm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89119819T
Other languages
English (en)
Inventor
Sudhakar S Dr Wagle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanol Schwarz GmbH
UCB Pharma GmbH
Original Assignee
Sanol Schwarz GmbH
Schwarz Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Schwarz GmbH, Schwarz Pharma AG filed Critical Sanol Schwarz GmbH
Application granted granted Critical
Publication of ES2048263T3 publication Critical patent/ES2048263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446Antibacterials

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UNA COMPOSICION (MDM) MEZCLA DETERMINANTE MENOR LIOFILIZADA, ESTABLE DE ALMACENAJE QUE PUEDEN SER RECONSTITUIDAS CON AGUA PARA PRODUCIR UNA SOLUCION QUE ES USADA PARA DETECTAR ALERGIAS O HIPERSENSIBILIDADES A PENICILINAS, COMPRENDEN: ACIDO BENCILPENILOICO; BENCILPENICILIN; ACIDO BENCILPENICILOICO EN DONDE AL MENOS SOBRE EL 94.5 % DEL ACIDO BENCILPENICILOICO ES EL ESTEROISOMERO (5R,6R)-BENCIL-D-ACIDO PENICILOICO; UNA SAL DE METAL ALCALI; UNA SUSTANCIA AMORTIGUADORA DE PH; Y UNA CANTIDAD BAJA CRITICAMENTE DE AGUA. EN EL METODO DEL INVENTO, ES PREPARADA UNA SOLUCION ACUOSA DE ACIDO BENCILPENILOICO, UNA SAL DE METAL ALCALI, Y UNA SUSTANCIA AMORTIGUADORA DE PH. EL ACIDO BENCILPENILOICO EN ESTA SOLUCION ES NEUTRALIZADA CON HIDROXIDO DE SODIO ACUOSO. MIENTRAS MANTENIENDO ESTA SOLUCION A UNA TEMPERATURA DESDE SOBRE 0 C A SOBRE 5 C, LOS SIGUIENTES PASOS SON REPRESENTADOS : PRIMERO, LOS ACIDOS BENCILPENICILIN Y EL BENCILPENICILOICO SON DISUELTOS DENTRO DE LA SOLUCION. EL ACIDO BENCILPENICILOICO EN LA SOLUCION ES NEUTRALIZADO CON HIDROXIDO DE SODIO ACUOSO. SIGUIENTE, EL PH DE LA SOLUCION ES AJUSTADO A UN PH FISIOLOGICO. ESTA SOLUCION ES ENTONCES FILTRADA ESTERIL. DESPUES DE REPRESENTAR ESOS PASOS EN EL QUE LA SOLUCION ES MANTENIDA A UNA TEMPERATURA DESDE SOBRE 0 C A SOBRE 5 C, LA SOLUCION ES CONGELADA EN CONTENEDORES DESHIDRATADOS. DESPUES DE CONGELAR, LA SOLUCION CONGELADA ES LIOFILIZADA.
ES89119819T 1988-11-01 1989-10-25 Composicion liofilizada de mdm y metodo para su fabricacion. Expired - Lifetime ES2048263T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26574988A 1988-11-01 1988-11-01

Publications (1)

Publication Number Publication Date
ES2048263T3 true ES2048263T3 (es) 1994-03-16

Family

ID=23011751

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89119819T Expired - Lifetime ES2048263T3 (es) 1988-11-01 1989-10-25 Composicion liofilizada de mdm y metodo para su fabricacion.

Country Status (7)

Country Link
EP (1) EP0367090B1 (es)
AT (1) ATE100210T1 (es)
DE (1) DE68912270T2 (es)
DK (1) DK542089A (es)
ES (1) ES2048263T3 (es)
IE (1) IE60788B1 (es)
PT (1) PT92163B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT1588U1 (de) * 1994-04-27 1997-08-25 Mahl Christian Dr Verfahren zur herstellung von testsubstanzen für verfahren mit erfassung elektromagnetischer schwingungen
CA2544816A1 (en) * 2003-11-08 2005-05-26 Prothera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
JP5793076B2 (ja) 2008-05-28 2015-10-14 プロセラ バイオロジクス, インコーポレイテッド 血液由来インター−アルファ−阻害タンパク質の調製及び組成物。
WO2014039987A2 (en) 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
US20140199286A1 (en) * 2013-01-15 2014-07-17 Teva Pharmaceutical Industries, Ltd. Lyophilization process
CA2896793A1 (en) 2013-01-15 2014-07-24 Teva Pharmaceutical Industries Ltd. Formulations of albu-bche, preparation and uses thereof
CN106187934A (zh) * 2016-07-08 2016-12-07 上海上药新亚药业有限公司 一种羧苄西林钠杂质g的合成方法
US20180326095A1 (en) * 2017-05-11 2018-11-15 AllerQuest LLC Kits and methods to detect penicillin allergy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316882A (en) * 1978-04-20 1982-02-23 Levine Bernard B Compositions for testing to predict and/or diagnose allergy to penicillins
US4183910A (en) * 1978-04-20 1980-01-15 Levine Bernard B Method for testing to predict and/or diagnose allergy to penicillins, and compounds and compositions for use in such tests
JPS63174927A (ja) * 1987-01-14 1988-07-19 Tanabe Seiyaku Co Ltd 抗菌性凍結乾燥製剤

Also Published As

Publication number Publication date
IE893397L (en) 1990-05-01
ATE100210T1 (de) 1994-01-15
DK542089A (da) 1990-05-02
PT92163A (pt) 1990-05-31
DE68912270D1 (de) 1994-02-24
EP0367090A1 (en) 1990-05-09
DK542089D0 (da) 1989-10-31
IE60788B1 (en) 1994-08-10
DE68912270T2 (de) 1994-04-28
PT92163B (pt) 1995-07-18
EP0367090B1 (en) 1994-01-12

Similar Documents

Publication Publication Date Title
ES8106653A1 (es) Procedimiento para la fabricacion de gamma-globulina para administracion intravenosa
IE912444A1 (en) Growth hormone crystals and a process for production of these GH-crystals
ES2048263T3 (es) Composicion liofilizada de mdm y metodo para su fabricacion.
DE69528166D1 (de) Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
KR880013572A (ko) 인슐린 및 인슐린 유도체의 혼합결정체, 이의 제조방법, 이를 함유하는 약제 및 이의 용도
ATE25807T1 (de) Kochsalzersatz-zusammensetzung.
PT86526A (pt) Processo para a preparacao de mono-hidrato de cefadroxil cristalino e de composicoes farmaceuticas que o contem
EP0207436A3 (en) New cytidine-diphosphocholine salts, particularly suitable for oral use
SU959786A1 (ru) Способ консервировани цельной крови
KR880000691B1 (ko) 세팔렉신의 수용성 유도체의 제조 방법
Weil-Malherbe On the synthesis of cocarboxylase
US4130558A (en) Process for preparation of alkali metal salts of ampicillin
DK167319B1 (da) Stabilt hydrat af et penicillinderivat og fremgangsmaade til fremstilling deraf
RU2080856C1 (ru) Способ получения инъекционной формы препарата атф
GB1240638A (en) Racemisation of alanine derivatives
US2438209A (en) Reaction product of gramicidin and formaldehyde and method of production
JPS649931A (en) Stabilized liposome preparation
SU455546A3 (ru) Способ выделени аспрагиназы
JPS6440591A (en) Production of warm and cold-reserving agent
SU712438A1 (ru) Способ получени лизоцима
GB2072675A (en) Cephapirin salts
GB736354A (en) Process for the production of preparation suitable as a blood plasma substitute
SU118588A1 (ru) Способ культивировани шизотрипанум круци
JPS6212727A (ja) 卵白分解物及びその製法
JPS645464A (en) Production of custard pudding preservable for long period

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367090

Country of ref document: ES